EU Pharmaceutical Sector Loses €10.2 Billion to Counterfeiting

IP Statistics: Counterfeit pharmaceuticals are costing the EU €10.2 billion a year, equivalent to 4.4% of sales, and around 37,700 jobs, according to a new report from the European Union Intellectual Property Office.